US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

TELA

TELA Bio (TELA)

TELA Bio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TELA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/21	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TELA	TELA Bio Inc
2024/05/21	05 : 03	GlobeNewswire Inc.	TELA Bio Appoints Greg Firestone as Chief Commercial Officer	NASDAQ:TELA	TELA Bio Inc
2024/05/11	05 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TELA	TELA Bio Inc
2024/05/11	05 : 05	GlobeNewswire Inc.	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TELA	TELA Bio Inc
2024/05/10	05 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TELA	TELA Bio Inc
2024/05/10	05 : 05	GlobeNewswire Inc.	TELA Bio Reports First Quarter 2024 Financial Results	NASDAQ:TELA	TELA Bio Inc
2024/04/25	20 : 00	GlobeNewswire Inc.	TELA Bio to Announce First Quarter 2024 Financial Results	NASDAQ:TELA	TELA Bio Inc
2024/04/15	20 : 00	GlobeNewswire Inc.	TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures	NASDAQ:TELA	TELA Bio Inc
2024/04/08	20 : 00	GlobeNewswire Inc.	TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy	NASDAQ:TELA	TELA Bio Inc
2024/03/22	05 : 05	GlobeNewswire Inc.	TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results	NASDAQ:TELA	TELA Bio Inc
2024/03/21	20 : 00	GlobeNewswire Inc.	TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery	NASDAQ:TELA	TELA Bio Inc
2024/03/20	20 : 00	GlobeNewswire Inc.	MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing	NASDAQ:TELA	TELA Bio Inc
2024/03/20	20 : 00	GlobeNewswire Inc.	TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX	NASDAQ:TELA	TELA Bio Inc
2024/02/29	21 : 00	GlobeNewswire Inc.	TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:TELA	TELA Bio Inc
2024/02/28	06 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TELA	TELA Bio Inc
2024/02/28	06 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TELA	TELA Bio Inc
2024/02/28	06 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TELA	TELA Bio Inc
2024/02/24	06 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TELA	TELA Bio Inc
2024/02/24	06 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TELA	TELA Bio Inc
2024/02/24	06 : 05	GlobeNewswire Inc.	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TELA	TELA Bio Inc
2024/02/17	06 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TELA	TELA Bio Inc
2024/02/17	06 : 05	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	NASDAQ:TELA	TELA Bio Inc
2024/02/15	07 : 23	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:TELA	TELA Bio Inc
2024/02/14	20 : 35	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:TELA	TELA Bio Inc
2024/01/20	06 : 05	GlobeNewswire Inc.	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TELA	TELA Bio Inc
2023/12/16	06 : 05	GlobeNewswire Inc.	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TELA	TELA Bio Inc
2023/12/08	06 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TELA	TELA Bio Inc
2023/12/05	21 : 00	GlobeNewswire Inc.	TELA Bio to Take Part in Connecting the Dots	NASDAQ:TELA	TELA Bio Inc
2023/11/21	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:TELA	TELA Bio Inc
2023/11/16	21 : 00	GlobeNewswire Inc.	TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference	NASDAQ:TELA	TELA Bio Inc

Showing the most relevant articles for your search:NASDAQ:TELA

1 2 3 4 5 6 7 8 9 10 次へ >>

CloudMD Software and Ser... (PK)

Vital Healthcare Property (PK)

JP Morgan US Tech Leader...

Btp Italia Gn30 Eur

Apollo Global Management LLC

Ethereum Express

Towngas Smart Energy

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約